WELLGISTICS HEALTH IN

Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025

27 مارس 2025 07:05:00 بحسب Nasdaq GlobeNewswire

Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models

18 مارس 2025 06:40:00 بحسب Nasdaq GlobeNewswire

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning’s Departure

04 مارس 2025 16:18:00 بحسب Nasdaq GlobeNewswire

Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™

04 مارس 2025 06:40:00 بحسب Nasdaq GlobeNewswire

Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market

26 فبراير 2025 06:40:00 بحسب Nasdaq GlobeNewswire

Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering

24 فبراير 2025 15:05:00 بحسب Nasdaq GlobeNewswire

Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering

21 فبراير 2025 07:05:00 بحسب Nasdaq GlobeNewswire